Your browser is no longer supported. Please, upgrade your browser.
AQST Aquestive Therapeutics, Inc. daily Stock Chart
AQST [NASD]
Aquestive Therapeutics, Inc.
Index- P/E- EPS (ttm)-2.62 Insider Own5.40% Shs Outstand29.61M Perf Week23.12%
Market Cap67.81M Forward P/E- EPS next Y-1.52 Insider Trans1.02% Shs Float26.62M Perf Month-35.67%
Income-66.20M PEG- EPS next Q-0.47 Inst Own58.60% Short Float7.01% Perf Quarter-62.46%
Sales52.60M P/S1.29 EPS this Y11.80% Inst Trans29.50% Short Ratio2.53 Perf Half Y-24.92%
Book/sh-0.23 P/B- EPS next Y14.10% ROA-107.90% Target Price17.17 Perf Year-62.70%
Cash/sh1.66 P/C1.38 EPS next 5Y- ROE371.70% 52W Range1.41 - 10.00 Perf YTD-60.65%
Dividend- P/FCF- EPS past 5Y-36.50% ROI-106.20% 52W High-77.10% Beta-
Dividend %- Quick Ratio3.50 Sales past 5Y90.00% Gross Margin61.30% 52W Low62.41% ATR0.37
Employees232 Current Ratio3.70 Sales Q/Q-2.40% Oper. Margin- RSI (14)42.67 Volatility13.89% 17.83%
OptionableYes Debt/Eq- EPS Q/Q14.70% Profit Margin- Rel Volume0.65 Prev Close2.02
ShortableYes LT Debt/Eq- EarningsMar 12 BMO Payout- Avg Volume738.51K Price2.29
Recom1.80 SMA20-12.98% SMA50-35.10% SMA200-46.59% Volume481,391 Change13.37%
Apr-22-19Initiated H.C. Wainwright Buy
Jan-03-19Initiated Lake Street Buy $14
Aug-20-18Initiated RBC Capital Mkts Outperform $23
Aug-20-18Initiated JMP Securities Mkt Outperform $29
Mar-17-20 07:00AM  Memgen Appoints Gregory Brown as Chief Executive Officer Newsfile +15.58%
Mar-14-20 08:15AM  Aquestive Therapeutics, Inc. Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock? Simply Wall St.
Mar-13-20 10:23AM  Company News for Mar 13, 2020 Zacks -12.50%
Mar-11-20 06:25PM  Aquestive Therapeutics (AQST) Reports Q4 Loss, Tops Revenue Estimates Zacks -14.53%
04:30PM  Aquestive Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights GlobeNewswire
Mar-05-20 12:30PM  Will Aquestive Therapeutics (AQST) Report Negative Earnings Next Week? What You Should Know Zacks
Mar-03-20 03:00PM  7 Cheap Stocks Under $7 With Massive Upside Potential Kiplinger
Feb-20-20 07:00AM  Aquestive Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights on March 12, 2020 GlobeNewswire
Feb-10-20 07:00AM  Aquestive Therapeutics Announces U.S. Food and Drug Administration Filing Acceptance of New Drug Application (NDA) for Libervant (diazepam) Buccal Film GlobeNewswire +17.93%
Feb-06-20 07:00AM  Aquestive Therapeutics Announces FDA Confirmed 505(b)(2) Pathway for AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine) for Anaphylaxis Treatment GlobeNewswire
Jan-29-20 12:30PM  3 Healthcare Stocks That Can Double This Year TipRanks
Jan-12-20 06:16PM  Aquestive Therapeutics Receives FDA Response to Citizens Petition GlobeNewswire
Jan-10-20 06:30AM  Aquestive Therapeutics Exceeds Top End of Guidance Range for Preliminary Unaudited Full Year 2019 Total Revenues and Provides Initial Full Year 2020 Guidance GlobeNewswire
Dec-22-19 06:09PM  Did Hedge Funds Drop The Ball On Aquestive Therapeutics, Inc. (AQST) ? Insider Monkey
Dec-17-19 05:31AM  Did Changing Sentiment Drive Aquestive Therapeutics's (NASDAQ:AQST) Share Price Down By 22%? Simply Wall St.
Dec-12-19 08:00PM  Aquestive Therapeutics Announces Pricing of Public Offering of Common Stock GlobeNewswire -12.99%
Dec-11-19 07:21AM  The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint Benzinga
Dec-10-19 04:01PM  Aquestive Therapeutics Announces Proposed Public Offering of Common Stock GlobeNewswire
Dec-09-19 10:04AM  Top Ranked Momentum Stocks to Buy for December 9th Zacks
Dec-04-19 08:30AM  Aquestive Therapeutics to Host Investor & Analyst Libervant (diazepam) Buccal Film Update Forum at American Epilepsy Society 2019 Annual Meeting GlobeNewswire
Dec-03-19 07:59AM  The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial Benzinga
Dec-02-19 07:30AM  Aquestive Therapeutics Completes Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Libervant (diazepam) Buccal Film for Management of Seizure Clusters GlobeNewswire +12.20%
Nov-29-19 10:29AM  These 3 Biotech Stocks Could More Than Double in 2020, Says Wedbush TipRanks +7.15%
Nov-26-19 04:05PM  A Deep Dive Into Aquestive Following The FDA's Approval Of Riluzole Benzinga
11:27AM  Aquestive Therapeutics Announces Poster Presentations of Data on Libervant (diazepam) Buccal Film at American Epilepsy Society 2019 Annual Meeting GlobeNewswire
11:07AM  Company News For Nov 26, 2019 Zacks
Nov-25-19 08:56AM  Aquestive shares jump on FDA approval MarketWatch +17.26%
08:00AM  Aquestive Therapeutics Receives FDA Approval for Exservan (riluzole) Oral Film GlobeNewswire
Nov-24-19 04:19PM  The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Arrowhead Earnings And More Benzinga
Nov-22-19 04:42PM  REFILE-FDA approves Aquestive's ALS treatment Reuters
Nov-14-19 01:31PM  Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks Zacks
Nov-13-19 08:30AM  Aquestive Therapeutics Licenses Riluzole Oral Film to Zambon for Development and Commercialization in the EU for Patients with ALS GlobeNewswire
Nov-11-19 09:00AM  All You Need to Know About Aquestive Therapeutics (AQST) Rating Upgrade to Buy Zacks +10.83%
Nov-07-19 09:42AM  Company News for Nov 7, 2019 Zacks
Nov-05-19 06:35PM  Aquestive Therapeutics (AQST) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:50PM  Aquestive Therapeutics Reports Third Quarter 2019 Financial Results and Raises 2019 Guidance GlobeNewswire
Oct-30-19 10:33AM  Analysts Estimate Aquestive Therapeutics (AQST) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-18-19 10:43AM  Have Insiders Been Buying Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares This Year? Simply Wall St.
Oct-16-19 07:06AM  The Daily Biotech Pulse: Akebia Sues CMS, Roche Raises Guidance Yet Again, Titan Medical Entangled In Credit Crunch Benzinga
Oct-15-19 05:41PM  Aquestive Therapeutics Reaffirms Full Year 2019 Revenue Guidance and Will Announce Third Quarter 2019 Financial Results and Recent Business Highlights on November 6, 2019 GlobeNewswire +5.03%
Sep-30-19 07:00AM  Aquestive Therapeutics Announces Successful Completion of Phase 1 Trial for AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine) GlobeNewswire
Sep-03-19 03:25PM  Market Sentiment Around Loss-Making Aquestive Therapeutics, Inc. (NASDAQ:AQST) Simply Wall St.
Aug-30-19 06:00AM  There's Value In These 2 Small Beaten Down Biotech Stocks TheStreet.com -5.00%
Aug-26-19 08:30AM  Aquestive Therapeutics to Attend Two Upcoming Investor Conferences GlobeNewswire
Aug-06-19 08:05PM  Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates Zacks
05:22PM  Aquestive Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights GlobeNewswire
04:28PM  Aquestive Therapeutics Announces Positive Topline Results from Libervant (Diazepam) Buccal Film Single Dose Crossover Study GlobeNewswire
Jul-31-19 10:36AM  Will Aquestive Therapeutics (AQST) Report Negative Earnings Next Week? What You Should Know Zacks
Jul-29-19 11:45AM  Aquestive Therapeutics to Present at 2019 Wedbush PacGrow Healthcare Conference GlobeNewswire
Jul-18-19 02:23PM  Aquestive Therapeutics to Announce Second Quarter 2019 Financial Results and Recent Business Highlights on August 7, 2019 PR Newswire
Jul-17-19 01:38PM  What Percentage Of Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Do Insiders Own? Simply Wall St.
Jul-15-19 04:35PM  Aquestive Therapeutics Completes $70 Million Debt Refinancing PR Newswire
Jun-07-19 08:30AM  Aquestive Therapeutics to Present at Two Upcoming Investor Conferences PR Newswire
Jun-04-19 08:00AM  Aquestive Therapeutics Completes Enrollment in Libervant (diazepam buccal film) Crossover Study PR Newswire
May-13-19 08:00AM  Aquestive Therapeutics to Present at Two Upcoming Investor Conferences PR Newswire -7.94%
May-08-19 07:31AM  Aquestive Therapeutics: 1Q Earnings Snapshot Associated Press -17.06%
07:00AM  IntelGenx and Aquestive Therapeutics Enter Worldwide Collaboration Agreement for Tadalafil GlobeNewswire
07:00AM  Aquestive Therapeutics Reports First Quarter 2019 Financial Results and Recent Business Highlights PR Newswire
May-07-19 07:00PM  Aquestive Therapeutics Announces Daniel Barber Named to Chief Operating Officer PR Newswire -6.20%
Apr-26-19 03:55PM  Need To Know: Aquestive Therapeutics, Inc. (NASDAQ:AQST) Insiders Have Been Buying Shares Simply Wall St.
Apr-17-19 05:17PM  Aquestive Therapeutics to Announce First Quarter 2019 Financial Results and Recent Business Highlights on May 8, 2019 PR Newswire
Apr-16-19 08:00AM  Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Acceptance of New Drug Application for Riluzole Oral Film for Treatment of ALS PR Newswire
Mar-25-19 04:25PM  Aquestive Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference PR Newswire
Mar-21-19 09:00AM  Aquestive Therapeutics (AQST) Upgraded to Buy: Here's Why Zacks
Mar-14-19 07:48AM  Aquestive Therapeutics: 4Q Earnings Snapshot Associated Press -15.96%
07:00AM  Aquestive Therapeutics, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights PR Newswire
Mar-07-19 02:34PM  Aquestive Therapeutics to Present at Oppenheimer's 29th Annual Healthcare Conference PR Newswire
Feb-19-19 09:00AM  Aquestive Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights on March 14, 2019 PR Newswire
Feb-08-19 09:00AM  Aquestive Therapeutics to Present at 2019 BIO CEO & Investor Conference PR Newswire
Feb-05-19 08:00AM  Aquestive Therapeutics Provides Update Regarding Suboxone® Sublingual Film Litigation PR Newswire
Jan-31-19 08:55AM  Aquestive Therapeutics Provides Update on Licensee, Sunovion Pharmaceuticals Inc.'s Apomorphine Sublingual Film (APL-130277) New Drug Application PR Newswire -14.27%
Jan-25-19 01:13PM  Aquestive Therapeutics Granted Temporary Restraining Order (TRO) Against Alvogen PR Newswire
Jan-03-19 06:11PM  Aquestive Therapeutics Appoints Gary H. Slatko, M.D. as Chief Medical Officer PR Newswire
Dec-21-18 11:11AM  Aquestive Therapeutics, Inc.s (NASDAQ:AQST) Shift From Loss To Profit Simply Wall St. -5.65%
Dec-20-18 07:30AM  Aquestive Therapeutics Provides End of Year Business Update, Including Progress of its Proprietary CNS Assets, Financial and Legal Matters PR Newswire
Dec-18-18 06:06PM  Aquestive Therapeutics Schedules Business Update Conference Call on December 20, 2018 PR Newswire -6.71%
Dec-07-18 08:00AM  Aquestive Therapeutics to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference PR Newswire -5.71%
Dec-03-18 11:00AM  Aquestive Therapeutics Announces Late-Breaking Findings of its Investigational Diazepam Buccal Film (DBF) Formulation in Adults with Epilepsy PR Newswire -5.01%
Nov-29-18 12:16PM  Aquestive Therapeutics Launches SYMPAZAN (clobazam) Oral Film with Widespread U.S. Availability PR Newswire
Nov-21-18 07:40AM  Market Trends Toward New Normal in Transcat, BioXcel Therapeutics, Youngevity International, Aquestive Therapeutics, TORM, and Transglobe Energy Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire -22.52%
Nov-18-18 04:06PM  The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates Benzinga
Nov-16-18 05:35PM  Aquestive Therapeutics Receives Complete Response Letter from U.S. Food and Drug Administration (FDA) for Tadalafil Oral Film PR Newswire
Nov-06-18 05:28PM  Aquestive Therapeutics: 3Q Earnings Snapshot Associated Press
04:02PM  Aquestive Therapeutics Reports Third Quarter 2018 Financial Results and Recent Business Highlights PR Newswire
Nov-02-18 08:00AM  Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval for SYMPAZAN (clobazam) Oral Film PR Newswire +13.71%
Oct-30-18 08:00AM  Aquestive Therapeutics to Present at the Stifel 2018 Healthcare Conference PR Newswire
Oct-25-18 05:00PM  Aquestive Therapeutics to Announce Third Quarter 2018 Financial Results and Recent Business Highlights on November 6, 2018 PR Newswire
08:00AM  Aquestive Therapeutics Announces Completion of Diazepam Buccal Film Adult Epilepsy Monitoring Unit (EMU) Clinical Study with Positive Topline Results PR Newswire
Sep-11-18 08:00AM  Aquestive Therapeutics Names Lori J. Braender, Esq. as Senior Vice President, General Counsel PR Newswire
Sep-04-18 07:00AM  Aquestive Therapeutics Reports Second Quarter 2018 Financial Results and Recent Business Highlights, Including Tentative Approval for Sympazan PR Newswire
Aug-31-18 02:30PM  Aquestive Therapeutics Announces Tentative FDA Approval for Sympazan (clobazam) Oral Film PR Newswire
Aug-15-18 04:00PM  Aquestive Therapeutics Announces Closing of Exercise of Underwriters' Over-Allotment Option in Initial Public Offering PR Newswire
Aug-13-18 08:00AM  Aquestive Therapeutics Names Sandy Costa as Chairman of the Board of Directors PR Newswire
Jul-31-18 07:00AM  Aquestive Therapeutics to Present at the 2018 Wedbush Healthcare Conference PR Newswire
Jul-27-18 04:00PM  Aquestive Therapeutics Announces Closing of Initial Public Offering PR Newswire
Jul-25-18 10:43AM  Aquestive Therapeutics shares surge 6.7% in trading debut MarketWatch
Jul-24-18 07:54PM  Aquestive Therapeutics Announces Pricing of Initial Public Offering PR Newswire
Aquestive Therapeutics, Inc., a specialty pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; and Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery in the United States and internationally. Its proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of recurrent epileptic seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of Amyotrophic Lateral Sclerosis. The company's proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation of epinephrine for the treatment of anaphylaxis; and AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly and neuroendocrine tumors. It also develops AQST-119, an oral soluble film formulation of tadalafil for the treatment of erectile dysfunction; and APL-130277, a sublingual film using apomorphine to treat parkinson's disease. Aquestive Therapeutics, Inc. was founded in 2004 and is headquartered in Warren, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BRAENDER LORI JSVP, General CounselMar 16Buy1.5414,00021,62425,000Mar 18 04:45 PM
Boyd Peter E.SVP-Bus. Process & Info. Tech.Mar 16Buy1.502,0003,00052,239Mar 18 04:45 PM
Kendall Keith JCEO and PresidentFeb 29Option Exercise0.0014,5720685,383Mar 03 07:37 PM
Schobel Alexander MarkChief Innovation/Tech OfficerFeb 29Option Exercise0.0014,57201,066,947Mar 03 07:38 PM
Schobel Alexander MarkChief Innovation/Tech OfficerDec 31Option Exercise0.0032901,044,494Jan 02 04:15 PM
Kendall Keith JCEO and PresidentDec 31Option Exercise0.003290662,985Jan 02 02:04 PM
Kendall Keith JCEO and PresidentNov 30Option Exercise0.0014,5720677,228Dec 02 04:56 PM
Schobel Alexander MarkChief Innovation/Tech OfficerNov 30Option Exercise0.0014,57201,058,737Dec 02 04:56 PM